GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (HAM:8SV) » Definitions » Total Equity

WPD Pharmaceuticals (HAM:8SV) Total Equity : €-0.41 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is WPD Pharmaceuticals Total Equity?

WPD Pharmaceuticals's total equity for the quarter that ended in Sep. 2024 was €-0.41 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

WPD Pharmaceuticals Total Equity Historical Data

The historical data trend for WPD Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Total Equity Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.64 0.71 -0.33 -0.38

WPD Pharmaceuticals Quarterly Data
Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.47 -0.38 -0.49 -0.46 -0.41

WPD Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

WPD Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=0.236-0.617
=-0.38

WPD Pharmaceuticals's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=0.195-0.609
=-0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WPD Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

WPD Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (HAM:8SV) » Definitions » Total Equity
Comparable Companies
TSXV:WAVE XCNQ:NSHS XCNQ:NIRV XCNQ:CHGX XCNQ:MYND VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX
Traded in Other Exchanges
WBIO:Canada
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
Website
https://www.wpdpharmaceuticals.com
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.

WPD Pharmaceuticals Headlines

No Headlines